Evidence map›Paper›PMID 26598495›Full record

ArticleBrain : a journal of neurology2015

Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer's disease.

Ian F Kimbrough, Stefanie Robel, Erik D Roberson, Harald Sontheimer

Open access · bronzeAbstract readVideo-Audio Media
In one paragraph

Article in Brain : a journal of neurology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 138 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Astrocytes as Therapeutic Targets in Neurodegenerative Disorders.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Astrovascular decoupling in awake 5×FAD mice is associated with reduced astrocytic calcium.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  9. Article
  10. Review
  11. Vascular Function and Ion Channels in Alzheimer's Disease.Microcirculation (New York, N.Y. : 1994) · 2024
    Review
  12. Review
  13. Article
  14. Alzheimer's disease pathophysiology in the Retina.Progress in retinal and eye research · 2024
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Endothelial Dysfunction in Neurodegenerative Diseases.International journal of molecular sciences · 2023
    Review
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ian F Kimbrough1 Department of Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA 2 Center for Glial Biology in Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Stefanie Robel1 Department of Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA 2 Center for Glial Biology in Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Erik D Roberson1 Department of Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA 3 Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA 4 Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL, USA sontheimer@vt.edu eroberson@uab.edu.
Harald Sontheimer1 Department of Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA 2 Center for Glial Biology in Medicine, University of Alabama at Birmingham, Birmingham, AL, USA sontheimer@vt.edu eroberson@uab.edu.
University of Alabama at Birmingham · US

Funding

The Role of Ion Transport in Glioma Migration, Proliferation, and ApoptosisR01NS036692 · NINDS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI SONTHEIMER, HARALD W · 1997 to 2024
$6.8M
PROPERTIES AND FUNCTION OF GLIA ION CHANNELSR01NS031234 · NINDS · YALE UNIVERSITY · PI SONTHEIMER, HARALD W · 1994 to 2011
$3.3M
Training Program in Brain Tumor BiologyT32NS048039 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BENVENISTE, ETTY N · 2007 to 2017
$2.0M
Mechanisms for the Benefit of Tau Reduction in Alzheimer Disease ModelsR01NS075487 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ROBERSON, ERIK D · 2011 to 2015
$1.6M
Glioma-Astrocyte Vascular InteractionsR01NS082851 · NINDS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI SONTHEIMER, HARALD W · 2013 to 2016
$1.3M
Regulation of the Vasculature by Invading Glioma CellsF31NS074597 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WATKINS, STACEY MICHELLE · 2011 to 2013
$55k
NINDS NIH HHS F31 NS074597NINDS NIH HHS F31NS074597NINDS NIH HHS R01 NS031234NINDS NIH HHS R01NS031234NINDS NIH HHS R01 NS036692NINDS NIH HHS R01NS036692NINDS NIH HHS R01 NS075487NINDS NIH HHS R01NS075487NINDS NIH HHS R01 NS082851NINDS NIH HHS R01NS082851NINDS NIH HHS T32 NS048039NINDS NIH HHS T32NS48039
6 · The paper itself

Abstract

Reduced cerebral blood flow impairs cognitive function and ultimately causes irreparable damage to brain tissue. The gliovascular unit, composed of neural and vascular cells, assures sufficient blood supply to active brain regions. Astrocytes, vascular smooth muscle cells, and pericytes are important players within the gliovascular unit modulating vessel diameters. While the importance of the gliovascular unit and the signals involved in regulating local blood flow to match neuronal activity is now well recognized, surprisingly little is known about this interface in disease. Alzheimer's disease is associated with reduced cerebral blood flow. Here, we studied how the gliovascular unit is affected in a mouse model of Alzheimer's disease, using a combination of ex vivo and in vivo imaging approaches. We specifically labelled vascular amyloid in living mice using the dye methoxy-XO4. We elicited vessel responses ex vivo using either pharmacological stimuli or cell-specific calcium uncaging in vascular smooth muscle cells or astrocytes. Multi-photon in vivo imaging through a cranial window allowed us to complement our ex vivo data in the presence of blood flow after label-free optical activation of vascular smooth muscle cells in the intact brain. We found that vascular amyloid deposits separated astrocyte end-feet from the endothelial vessel wall. High-resolution 3D images demonstrated that vascular amyloid developed in ring-like structures around the vessel circumference, essentially forming a rigid cast. Where vascular amyloid was present, stimulation of astrocytes or vascular smooth muscle cells via ex vivo Ca(2+) uncaging or in vivo optical activation produced only poor vascular responses. Strikingly, vessel segments that were unaffected by vascular amyloid responded to the same extent as vessels from age-matched control animals. We conclude that while astrocytes can still release vasoactive substances, vascular amyloid deposits render blood vessels rigid and reduce the dynamic range of affected vessel segments. These results demonstrate a mechanism that could account in part for the reduction in cerebral blood flow in patients with Alzheimer's disease.media-1vid110.1093/brain/awv327_video_abstractawv327_video_abstract.

Indexed as

Alzheimer DiseaseAmyloid beta-Protein PrecursorAmyloidosisAnimalsAstrocytesBrainDisease Models, AnimalHumansMaleMiceMice, TransgenicMuscle, Smooth, VascularPlaque, AmyloidAmyloid beta-Protein PrecursorAlzheimer’s diseaseamyloidosismulti-photon imagingneurovascular couplingvascular amyloid

Identifiers

PMID26598495
PMCPMC5006220
OpenAlexW2202769705

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.